Opioids Market Research Reports
Sort By :
TITLE Price Buy
Now More options
Leading business intelligence provider GBI Research has released its latest research report, entitled Opioids Market to 2018 - Increasing Concentration of Abuse-Resistant Branded Generics Alter Competitive Dynamics in this Flat Market&rdquo...
|
$ 3500
|
|
|
GBI Research, the leading business intelligence provider, has released its latest research, Prescribing Trends in Opioids- Driven by Efficacy Advantages, Opioids to Remain the Mainstay of Breakthrough Pain Management”, provides in-dep...
|
$ 3500
|
|
|
GBI Research, the leading business intelligence provider, has released its latest research, Opioids Market to 2017 - Steady Uptake of Oxycontin and High Incidence Of Diseases Suc...
|
$ 3500
|
|
|
GBI Research's research, Risk Evaluation and Mitigation Strategy (REMS) - Opioids, Erythropoesis-Stimulating Agents and Cancer Therapeutics are the Most Important Classes Tha...
|
$ 3500
|
|
|
IntroductionThe moderate to severe chronic nociceptive pain market has boomed in the years since the removal of generic extended-release oxycodone from the US, growing in value to eclipse $10 billion. However, this reprieve...
|
$ 15200
|
|
|
IntroductionThe Australian opioid market grew from $63m in 2005 to $137m in 2009. Its growth will slow considerably and the market will be worth $182m in 2019. As many new drugs to come on the market will be reformulations, Datamonit...
|
$ 5700
|
|
|
IntroductionThe Australian opioid market grew from $63m in 2005 to $137m in 2009. Its growth will slow considerably and the market will be worth $182m in 2019. As many new drugs to come on the market will be reformulations, Datamonit...
|
$ 5700
|
|
|
IntroductionThe opioids market is set to grow from $9.6 billion in 2008 to $11.9 billion in 2018 across the seven major markets. However, the number and diversity of products in late-stage development will limit the commercial potent...
|
$ 15200
|
|
|